| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/12/2009 | US7531530 derivatives of tricyclic lactam indoles and tricyclic lactam benzimidazoles; poly (ADP-ribose) polymerase (PARP) inhibitors; breast cancer, cancers caused by genetic defect in a gene; side effects reduction by not administering as a combination therapy; low doses; antiapoptosis; BRCA1 or BRCA2 expression |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531518 Method for fostering bone formation and preservation |
| 05/12/2009 | US7531517 Dipeptide containing an imidazolidinedione or a pyrimidinedione group; inhibitors of the proteasome of cathepsins, especially cathepsin S, or of other proteases |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence |
| 05/12/2009 | US7531514 Orally administered peptides synergize statin activity |
| 05/12/2009 | US7531513 Therapeutic preparation of very high purity FVIIa and method for obtaining same |
| 05/12/2009 | US7531512 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 05/12/2009 | US7531511 Injecting fibroblast growth factor-2 directly into the myocardium |
| 05/12/2009 | US7531510 Methods of recruiting fibroblasts by administering G-CSF |
| 05/12/2009 | US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 05/12/2009 | US7531508 The variant has an altered A-B loop and is therefore predicted to possess altered receptor binding properties; for use in therapy or diagnosis of a disease in which human growth hormone is implicated |
| 05/12/2009 | US7531507 Such as 3-tert-Butyl-D-alanyl-3-(6-trifluoromethylpyridin-3-yl)-L-alanyl-de(1-D-leucyl-2-L-leucyl)-lysobactin bistrifluoroacetate; cell wall biosynthesis inhibitors; treatment and/or prophylaxis of bacterial infectious diseases |
| 05/12/2009 | US7531506 Process for producing trunkamide a compounds |
| 05/12/2009 | US7531505 Coating composition containing a protein with a metallic surface-binding domain and an endothelial-binding domain and may have terminal modifications; coating stainless steel stents |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531503 Cell scaffold matrices with incorporated therapeutic agents |
| 05/12/2009 | US7531502 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
| 05/12/2009 | US7531501 Method of treating endothelial injury |
| 05/12/2009 | US7531500 Preventing airway mucus production by administration of EGF-R antagonists |
| 05/12/2009 | US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine |
| 05/12/2009 | US7531347 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 05/12/2009 | US7531341 wild-type algae lyase enzymes comprising polyethylene glycol, used for treating pregnant females having hyperphenylalaninemia |
| 05/12/2009 | US7531324 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531323 Diabetes-mediating proteins and therapeutic uses thereof |
| 05/12/2009 | US7531321 Fibroblast growth factor-like molecules and uses thereof |
| 05/12/2009 | US7531313 Screening for agents that modulate relaxin function |
| 05/12/2009 | US7531311 determining the amount of a polynucleotide sequence or a fragment of at least 20 consecutive nucleotides in a test sample and comparing the amount with that from a control, wherein an increase indicates a gastrointestinal disorder |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | US7531180 Chimeric alphavirus replicon particles |
| 05/12/2009 | US7531179 Bipolymer conjugate comprising botulin-a peptide for use in conferring tolerance to clostridial toxin |
| 05/12/2009 | US7531178 Immunoadhesin comprising a glycoprotein VI domain |
| 05/12/2009 | US7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering; |
| 05/12/2009 | US7531173 Ophthalmic composition comprising vascular endothelial growth factor antagonist for use in prevention and treatment of vision defects |
| 05/12/2009 | US7531172 administering vascular endothelial growth factor (VEGF) inhibitors, to reduce or prevent hypertension |
| 05/12/2009 | CA2643508A1 Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 05/12/2009 | CA2590293C Use of the neurotoxic component of botulinum to treat a spastic muscle |
| 05/12/2009 | CA2589989C The use of the neurotoxic component of a botulinum toxin for the treatment of exessive sweating |
| 05/12/2009 | CA2518102C Powdery preparation for nasal administration |
| 05/12/2009 | CA2417316C Process for the preparation of amylase inhibitor |
| 05/12/2009 | CA2412561C Highly efficient delivery of a large therapeutic mass aerosol |
| 05/12/2009 | CA2400143C Recombinant conglutinin and producing method thereof |
| 05/12/2009 | CA2335353C Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
| 05/12/2009 | CA2253997C Phosphonic acid-substituted benzazepinone-n-acetic acid derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 05/12/2009 | CA2224709C Oral drugs and functional foods for treating and preventing rheumatoid arthritis |
| 05/12/2009 | CA2213254C Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/12/2009 | CA2157864C Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/12/2009 | CA2109977C Giardia vaccines |
| 05/09/2009 | CA2611540A1 Sugar chain-containing albumin, production method thereof and use thereof |
| 05/07/2009 | WO2009059309A2 Furin-cleavable peptide linkers for drug-ligand conjugates |
| 05/07/2009 | WO2009059289A2 Netrin-1 compositions and methods of use thereof |
| 05/07/2009 | WO2009059082A2 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 05/07/2009 | WO2009059011A2 Hla-dr binding peptides and their uses |
| 05/07/2009 | WO2009058957A2 Intranasal administration of active agents to the central nervous system |
| 05/07/2009 | WO2009058895A1 Administration of an inhibitor of hdac and an mtor inhibitor |
| 05/07/2009 | WO2009058835A1 Method of determining vaccine compliance |
| 05/07/2009 | WO2009058734A1 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 05/07/2009 | WO2009058400A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | WO2009058322A1 Albumin fusion proteins |
| 05/07/2009 | WO2009058136A1 An orally-absorbed solid dose formulation for vancomycin |
| 05/07/2009 | WO2009057982A1 Composition and method for preventing and treating immune-related disorder |
| 05/07/2009 | WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein |
| 05/07/2009 | WO2009057785A1 Process for producing medicinal preparation packed with drug instable to heat |
| 05/07/2009 | WO2009057724A1 Jew's mallow-derived synthetic-resin-adsorbed fraction composition having vasodepressing activity, vasodepressing agent or food/beverage comprising the adsorbed fraction composition, and method for producing the adsorbed fraction composition |
| 05/07/2009 | WO2009057622A1 Method for production of human growth hormone improved in efficiency |
| 05/07/2009 | WO2009057568A1 Polypeptide compound |
| 05/07/2009 | WO2009057461A1 Therapeutic agent for diabetes |
| 05/07/2009 | WO2009057287A1 Food material for inhibiting the formation of osteoclast |
| 05/07/2009 | WO2009057282A1 Food material for inhibiting bone resorption |
| 05/07/2009 | WO2009057281A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 05/07/2009 | WO2009057280A1 Bone-strengthening food material |
| 05/07/2009 | WO2009056833A2 Composition |
| 05/07/2009 | WO2009056584A1 Anticomplement polypeptides of ixodes ricinus |
| 05/07/2009 | WO2009056580A1 Rabbit monoclonal antibody (mab cv152) anti-indoleamine 2 3-dioxygenase (ido) |
| 05/07/2009 | WO2009056569A1 Lh liquid formulations |
| 05/07/2009 | WO2009056547A1 Vancomycin and teicoplanin anhydrous formulations for topical use |
| 05/07/2009 | WO2009056434A1 Combination products for treating cancer |
| 05/07/2009 | WO2009056419A1 Methods for producing a non human animal model for aortic aneurysm |
| 05/07/2009 | WO2009056330A1 Soluble truncated apom proteins and medical uses thereof |
| 05/07/2009 | WO2009055937A1 Altered n-cadherin processing in tumor cells by furln and proproteln convertase 5a (pc5a) |
| 05/07/2009 | WO2009055934A1 Treatment of fibrillinopathy or elastinopathy using granzyme inhibitors |
| 05/07/2009 | WO2009055923A1 Ingestible film composition |
| 05/07/2009 | WO2009055907A1 Apoptin induces inhibition of bcr-abl kinase in cml cells |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009042642A3 Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2009033489A3 Selective pacl inhibitors for use in the treatment of migraine and headaches |
| 05/07/2009 | WO2009032256A3 Apc activators in combination with a cytokine-secreting cell and methods of use thereof |
| 05/07/2009 | WO2009032172A3 Platinum compositions as treatment for oct-related cancers |
| 05/07/2009 | WO2009031835A3 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
| 05/07/2009 | WO2009031051A9 Stabilized anthocyanin compositions |
| 05/07/2009 | WO2009009727A3 Ghrh analogs and therapeutic uses thereof |
| 05/07/2009 | WO2008148563A3 Viral latency model |
| 05/07/2009 | WO2008112543A3 Rat, rabbit, and cynomolgus monkey il-21 and il-22 nucleotide and polypeptide sequences |